Skip to main content
Log in

Diagnostic and clinical utility of genetic testing in children with kidney failure

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

Genetic kidney disease is well established as an important cause of pediatric kidney failure, and genetic testing might increase diagnostic accuracy, but evidence is limited. This study was conducted to determine the diagnostic yield and clinical impact of genetic testing for children with kidney failure.

Methods

Patients who were diagnosed with kidney failure before 19 years of age at Children’s Hospital of Fudan University from 2009 to 2018 and received next-generation sequencing (NGS) were enrolled. The results for likely pathogenic variants in genes known to cause chronic kidney disease (CKD) were analyzed.

Results

A molecular diagnosis was identified in 39.9% (75/188) of children with kidney failure. Specific subtype of clinical category was discerned in 54 (72.0%) patients, kidney disease was reclassified in 7 (9.3%) patients, the unknown etiology of 5 (6.7%) patients was molecularly diagnosed, and the clinical diagnoses of the other 9 (12.0%) patients were confirmed. In addition, genetic diagnosis was considered to have contributed to clinical management, including negating the need for kidney biopsy (26/75, 34.7%), avoiding immunosuppressive therapy (24/75, 32.0%), changing surveillance (48/75, 64.0%), guiding specific treatment (21/75, 28.0%), and guiding peri-transplant management and options for kidney transplantation (12/75, 16.0%). Furthermore, cascade testing was subsequently offered to 34.7% (26/75) of families.

Conclusions

Genetic testing identified a molecular diagnosis in nearly 40% of children with kidney failure. Our results confirm that in children with kidney failure, genetic testing can not only establish a specific molecular diagnosis, but has a significant impact on clinical management.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Availability of data and materials

All data generated or analyzed are included in this paper.

Code availability

Not applicable.

References

  1. Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C (2019) A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Nephrol Dial Transplant 34:1803–1805

    Article  Google Scholar 

  2. Chua A, Cramer C, Moudgil A, Martz K, Smith J, Blydt-Hansen T, Neu A, Dharnidharka VR, NAPRTCS investigators (2019) Kidney transplant practice and outcome benchmarks over 30 years: The 2018 report of the NAPRTCS. Pediatr Transplant 23:e13597

    Article  Google Scholar 

  3. Shen Q, Fang X, Man X, Zhai Y, Liu L, Wang C, Shang W, Feng G, Zhang L, Zeng L, Zhu Y, Chen J, Rao J, Warady BA, Schaefer F, Xu H (2021) Pediatric kidney transplantation in China: an analysis from the IPNA Global Kidney Replacement Therapy Registry. Pediatr Nephrol 36:685–692

    Article  Google Scholar 

  4. de Haan A, Eijgelsheim M, Vogt L, Knoers NVAM, de Borst MH (2019) Diagnostic yield of next-generation sequencing in patients with chronic kidney disease of unknown etiology. Front Genet 10:1264

    Article  Google Scholar 

  5. Jayasinghe K, Stark Z, Kerr PG, Gaff C, Martyn M, Whitlam J, Creighton B, Donaldson E, Hunter M, Jarmolowicz A, Johnstone L, Krzesinski E, Lunke S, Lynch E, Nicholls K, Patel C, Prawer Y, Ryan J, See EJ, Talbot A, Trainer A, Tytherleigh R, Valente G, Wallis M, Wardrop L, West KH, White SM, Wilkins E, Mallett AJ, Quinlan C (2021) Clinical impact of genomic testing in patients with suspected monogenic kidney disease. Genet Med 23:183–191

    Article  Google Scholar 

  6. Mann N, Braun DA, Amann K, Tan W, Shril S, Connaughton DM, Nakayama M, Schneider R, Kitzler TM, van der Ven AT, Chen J, Ityel H, Vivante A, Majmundar AJ, Daga A, Warejko JK, Lovric S, Ashraf S, Jobst-Schwan T, Widmeier E, Hugo H, Mane SM, Spaneas L, Somers MJG, Ferguson MA, Traum AZ, Stein DR, Baum MA, Daouk GH, Lifton RP, Manzi S, Vakili K, Kim HB, Rodig NM, Hildebrandt F (2019) Whole-exome sequencing enables a precision medicine approach for kidney transplant recipients. J Am Soc Nephrol 30:201–215

    Article  CAS  Google Scholar 

  7. Rao J, Liu X, Mao J, Tang X, Shen Q, Li G, Sun L, Bi Y, Wang X, Qian Y, Wu B, Wang H, Zhou W, Ma D, Zheng B, Shen Y, Chen Z, Luan J, Wang X, Wang M, Dang X, Wang Y, Wu Y, Hou L, Sun S, Li Q, Liu X, Bai H, Yang Y, Shao X, Li Y, Zheng S, Han M, Liu C, Cao G, Zhao L, Qiu S, Dong Y, Zhu Y, Wang F, Zhang D, Li Y, Zhao L, Yang C, Luo X, Chen L, Jiang X, Zhang A, Xu H, for “Internet Plus” Nephrology Alliance of National Center for Children's Care (2019) Genetic spectrum of renal disease for 1001 Chinese children based on a multicenter registration system. Clin Genet 96:402–410

    Article  CAS  Google Scholar 

  8. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG Laboratory Quality Assurance Committee (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424

    Article  Google Scholar 

  9. Groopman EE, Marasa M, Cameron-Christie S, Petrovski S, Aggarwal VS, Milo-Rasouly H, Li Y, Zhang J, Nestor J, Krithivasan P, Lam WY, Mitrotti A, Piva S, Kil BH, Chatterjee D, Reingold R, Bradbury D, DiVecchia M, Snyder H, Mu X, Mehl K, Balderes O, Fasel DA, Weng C, Radhakrishnan J, Canetta P, Appel GB, Bomback AS, Ahn W, Uy NS, Alam S, Cohen DJ, Crew RJ, Dube GK, Rao MK, Kamalakaran S, Copeland B, Ren Z, Bridgers J, Malone CD, Mebane CM, Dagaonkar N, Fellström BC, Haefliger C, Mohan S, Sanna-Cherchi S, Kiryluk K, Fleckner J, March R, Platt A, Goldstein DB, Gharavi AG (2019) Diagnostic utility of exome sequencing for kidney disease. N Engl J Med 380:142–151

    Article  CAS  Google Scholar 

  10. Ottlewski I, Münch J, Wagner T, Schönauer R, Bachmann A, Weimann A, Hentschel J, Lindner TH, Seehofer D, Bergmann C, Jamra RA, Halbritter J (2019) Value of renal gene panel diagnostics in adults waiting for kidney transplantation due to undetermined end-stage renal disease. Kidney Int 96:222–230

    Article  Google Scholar 

  11. Vivante A, Hildebrandt F (2016) Exploring the genetic basis of early-onset chronic kidney disease. Nat Rev Nephrol 12:133–146

    Article  CAS  Google Scholar 

  12. Connaughton DM, Bukhari S, Conlon P, Cassidy E, O'Toole M, Mohamad M, Flanagan J, Butler T, O'Leary A, Wong L, O'Regan J, Moran S, O'Kelly P, Logan V, Griffin B, Griffin M, Lavin P, Little MA, Conlon P (2015) The Irish Kidney Gene Project—prevalence of family history in patients with kidney disease in Ireland. Nephron 130:293–301

    Article  Google Scholar 

  13. Skrunes R, Svarstad E, Reisæter AV, Vikse BE (2014) Familial clustering of ESRD in the Norwegian population. Clin J Am Soc Nephrol 9:1692–1700

    Article  Google Scholar 

  14. Akrawi DS, Li X, Sundquist J, Sundquist K, Zöller B (2014) Familial risks of kidney failure in Sweden: a nationwide family study. PLoS One 9:e113353

    Article  Google Scholar 

  15. Braun DA, Schueler M, Halbritter J, Gee HY, Porath JD, Lawson JA, Airik R, Shril S, Allen SJ, Stein D, Al Kindy A, Beck BB, Cengiz N, Moorani KN, Ozaltin F, Hashmi S, Sayer JA, Bockenhauer D, Soliman NA, Otto EA, Lifton RP, Hildebrandt F (2016) Whole exome sequencing identifies causative mutations in the majority of consanguineous or familial cases with childhood-onset increased renal echogenicity. Kidney Int 89:468–475

    Article  CAS  Google Scholar 

  16. Hildebrandt F (2010) Genetic kidney diseases. Lancet 375:1287–1295

    Article  CAS  Google Scholar 

  17. Niaudet P, Gubler MC (2006) WT1 and glomerular diseases. Pediatr Nephrol 21:1653–1660

    Article  Google Scholar 

  18. Sun S, Xu L, Bi Y, Wang J, Zhang Z, Tang X, Cao Q, Zhai Y, Chen J, Fang X, Liu J, Fang Y, Xiang T, Qian Y, Wu B, Wang H, Zhou W, Shen J, Dong K, Liu X, Zheng B, Zhang A, Wang X, Wu Y, Ma D, Shen Q, Rao J, Xu H (2020) Early diagnosis of WT1 nephropathy and follow up in a Chinese multicenter cohort. Eur J Med Genet 63:104047

    Article  Google Scholar 

  19. Cochat P, Hulton SA, Acquaviva C, Danpure CJ, Daudon M, De Marchi M, Fargue S, Groothoff J, Harambat J, Hoppe B, Jamieson NV, Kemper MJ, Mandrile G, Marangella M, Picca S, Rumsby G, Salido E, Straub M, van Woerden CS (2012) Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment. Nephrol Dial Transplant 27:1729–1736

    Article  CAS  Google Scholar 

  20. Robbiano A, Mandrile G, De Marchi M, Beck B, Baasner A, Murer L, Benetti E, Giachino D (2010) Novel human pathological mutations. Gene symbol: AGXT. Disease: hyperoxaluria. Hum Genet 127:468

    PubMed  Google Scholar 

  21. Trautmann A, Bodria M, Ozaltin F, Gheisari A, Melk A, Azocar M, Anarat A, Caliskan S, Emma F, Gellermann J, Oh J, Baskin E, Ksiazek J, Remuzzi G, Erdogan O, Akman S, Dusek J, Davitaia T, Özkaya O, Papachristou F, Firszt-Adamczyk A, Urasinski T, Testa S, Krmar RT, Hyla-Klekot L, Pasini A, Özcakar ZB, Sallay P, Cakar N, Galanti M, Terzic J, Aoun B, Caldas Afonso A, Szymanik-Grzelak H, Lipska BS, Schnaidt S, Schaefer F, PodoNet Consortium (2015) Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. Clin J Am Soc Nephrol 10:592–600

    Article  Google Scholar 

  22. Ding WY, Koziell A, McCarthy HJ, Bierzynska A, Bhagavatula MK, Dudley JA, Inward CD, Coward RJ, Tizard J, Reid C, Antignac C, Boyer O, Saleem MA (2014) Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence. J Am Soc Nephrol 25:1342–1348

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank all patients and their families who contributed to this study. We thank the coordinators of the Chigene (Beijing) Translational Medical Research Center Co. Ltd., WuXi NextCODE in Shanghai, and MyGenostics Co. Ltd. in Beijing, for sequencing technology support.

Author information

Authors and Affiliations

Authors

Contributions

J. Chen, F. Lin, Y. Zhai, Q. Shen, and H. Xu contributed to the research design; B. Wu, D. Ma, and H. Xu provided administrative, technical, and material support; F. Lin, C. Wang, J. Rao, Jiaojiao Liu, Jialu Liu, and M. Yu contributed to data acquisition; J. Chen, F. Lin, and Y. Zhai contributed to data analysis and interpretation; J. Chen, F. Lin, and M. Yu contributed to statistical analysis; J. Chen and Q. Shen drafted the manuscript; Q. Shen and H. Xu contributed critical revisions of the manuscript; Q. Shen and H. Xu contributed supervision and mentorship; and all authors approved the final version of the report.

Corresponding authors

Correspondence to Qian Shen or Hong Xu.

Ethics declarations

Ethics approval

This study was approved by the Ethical Review Committee of the Children’s Hospital of Fudan University.

Consent to participate

Not applicable.

Conflict of interest

All authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(DOCX 7667 kb).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, J., Lin, F., Zhai, Y. et al. Diagnostic and clinical utility of genetic testing in children with kidney failure. Pediatr Nephrol 36, 3653–3662 (2021). https://doi.org/10.1007/s00467-021-05141-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-021-05141-5

Keywords

Navigation